The Next Wave of Therapeutics for CKD? Navigating Incretin-Based Therapies & the Kidney

Time: 8:00 am
day: Day One


• From pathogenesis to therapeutic intervention: incretin-based drugs and the kidney in type 2 diabetes
• Developing incretin-based therapies for the treatment of kidney disease
• Investigating the impact of multiple clinical comorbidities including cardiovascular diseases, NASH, and CKD